Novel targets for gastric cancer: The tumor microenvironment (TME), N6-methyladenosine (m6A), pyroptosis, autophagy, ferroptosis and cuproptosis

• Published in: Biomedicine & pharmacotherapy Vol. 163; p. 114883
• Main Authors: Yang, Peizheng, Yang, Wanting, Wei, Zhong, Li, Yan, Yang, Yinfeng, Wang, Jinghui
• Format: Journal Article
• Language: English
• Published: France Elsevier Masson SAS 01.07.2023; Elsevier
• Subjects: Adenosine; Autophagy; Cuproptosis; Ferroptosis; Gastric cancer (GC); Humans; N6-methyladenosine (m6A); Pyroptosis; Stomach Neoplasms - drug therapy; The tumor microenvironment (TME); Tumor Microenvironment; N6-methyladenosine (m6A); Pyroptosis; Cuproptosis; Gastric cancer (GC); Ferroptosis; The tumor microenvironment (TME); Autophagy
• ISSN: 0753-3322; 1950-6007
• DOI: 10.1016/j.biopha.2023.114883

Gastric cancer (GC) is a fatal illness, and its mortality rate is very high all over the world. At present, it is a serious health problem for any country. It is a multifactorial disease due to the rising drug resistance and the increasing global cancer burden, the treatment of GC still faces many obstacles and problems. In recent years, research on GC is being carried out continuously, and we hope to address the new targets of GC treatment through this review. At the same time, we also hope to discover new ways to fight GC and create more gospel for clinical patients. First, we discuss the descriptive tumor microenvironment (TME), N6-methyladenosine (m6A), pyroptosis, autophagy, ferroptosis, and cuproptosis. Finally, we expounded on the new or potential targets of GC treatment.